TABLE 1.
Vitexin | Study | Oxidative and defense biomarkers | Signaling and gene expression | Ref. |
---|---|---|---|---|
In vitro concentration | ||||
10 µM | NMDA (200 μM) and glycine (10 μM)‐induced toxicity in cultured cortical neurons |
Increased Bcl‐2 Decreased Bax protein and the ratio of Bax/Bcl‐2 expression Downregulated the protein levels of NR2B‐containing NMDA receptors Reduced the overload of intracellular Ca2+ |
Yang, Yang, Zhang, Tian, Liu, and Zhao (2014) | |
10 and 100 µM, 24 hr | Exposure to isoflurane (1.4%) in human PC12 cells | Decreased ROS levels, increased GSH and SOD |
Inhibited the level of pro‐inflammatory cytokines (TNF‐α and IL‐6) Decreased caspase‐3, BACE protein expression levels, cytosolic calcium levels, TRPV1, and NR2B protein expression levels |
Chen, Zhang, Shan, and Zhao (2016) |
50 µM | Glutamate (5 mM)‐induced cytotoxicity in Neuro‐2a cells | Decreased MDA and NO production |
Upregulation of antioxidant response genes (Nrf2, HO‐1, NQO‐1, and Grp78) Downregulated Gadd153 Preserved MMP Suppressed cyclophilin D expression Downregulated NMDR and calpain gene expression Increased Bcl‐2/Bax ratio Decreased caspase‐3 Increased GLAST‐1, GLT‐1) |
Malar, Prasant, et al. (2018) |
Abbreviations: BACE, β‐site amyloid precursor protein (APP) cleaving enzyme 1; Gadd153, Growth arrest and DNA damage 153; GLAST‐1; GLT‐1, Glutamate transporters; Grp 78,78‐kDa Glucose‐regulated protein; GSH, Glutathione; Heme oxygenase 1; HO‐1; MDA, Malondialdehyde; MMP, Mitochondrial membrane potential; NMDA, N‐methyl‐D‐aspartate; NO, Nitric oxide; NQO‐1, NADH‐quinone oxidoreductase; NR2B, N‐methyl D‐aspartate receptor subtype 2B; Nrf‐2, Nuclear factor erythroid 2‐related factor 2; ROS, Reactive oxygen species; SOD, Superoxide dismutase.